Dermatological Adverse Effects of Covid-19 Vaccine among Healthcare Workers: Findings from a Tertiary Care Hospital in Northern India

Author:

Choudhary Harshita1,Wason Rhea1,Goel Madhav1,Relhan Vineet2,Majhi Madan Mohan3

Affiliation:

1. Intern, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, Delhi, India

2. Department of Dermatology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, Delhi, India

3. Assistant Professor, Department of Community Medicine, SCB Medical College, Cuttack, Odisha, India,

Abstract

Objectives: The objective of this study was to identify the cutaneous manifestations that developed after covid-19 vaccination, with Covaxin and Covishield, in healthcare workers (HCW) and to identify any associated factors. Materials and Methods: A cross-sectional study was conducted over 3 months using an online and offline questionnaire that was circulated among the HCW working at a tertiary care hospital in Delhi. All the vaccinated HCWs who gave consent (n = 676) (n = number of participants) were included in the study. Data were summarised in an excel sheet and then analysed using SPSS, version 25. Results: Out of the 676 vaccine recipients, a higher number of participants were vaccinated with Covishield compared to Covaxin. Only 14 (2.0%) subjects developed new adverse dermatological manifestations following either vaccination. A higher incidence of adverse reaction was observed with Covaxin than with Covishield, but the difference was not significant. A significantly higher number of vaccinated paramedical workers developed new dermatological manifestations in the study period [P-value (probability value)] (P = 0.018). Conclusion: Our study demonstrated a low rate of cutaneous adverse reactions following vaccination with either Covaxin or Covishield. Further studies are hence needed to corroborate our findings.

Publisher

Scientific Scholar

Reference15 articles.

1. 30 Million Frontline Workers to Get covid-19 Vaccine in Phase 1 Hindustan Times;Hindustan Times,2020

2. India Rolls out the World’s Largest covid-19 Vaccination Drive;World Health Organization,2021

3. India’s Drugs Experts Approve AstraZeneca;Reuters;Local Covid Vaccines,2021

4. Johnson and Johnson’s Jab Added to List: India Now Has 5 Vaccines for Adults;News 18;All You Need to Know:@cnnnews18,2021

5. Zydus Cadila: What We Know about India’s New covid Vaccines BBC News;BBC News,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3